Yangmin Hu

573 total citations
20 papers, 351 citations indexed

About

Yangmin Hu is a scholar working on Molecular Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Yangmin Hu has authored 20 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Medicine, 4 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Yangmin Hu's work include Antibiotic Resistance in Bacteria (7 papers), Pharmaceutical Practices and Patient Outcomes (3 papers) and Antibiotic Use and Resistance (2 papers). Yangmin Hu is often cited by papers focused on Antibiotic Resistance in Bacteria (7 papers), Pharmaceutical Practices and Patient Outcomes (3 papers) and Antibiotic Use and Resistance (2 papers). Yangmin Hu collaborates with scholars based in China and United States. Yangmin Hu's co-authors include Haibin Dai, Huimin Xu, Xiaofeng Yan, Wenlu Li, Ping He, Gensheng Zhang, Danyang Li, Hongjiao Xu, Yuping Hu and Jing Ren and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Frontiers in Physiology.

In The Last Decade

Yangmin Hu

17 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yangmin Hu China 13 103 80 67 60 57 20 351
Zahra Sahraei Iran 6 145 1.4× 72 0.9× 109 1.6× 36 0.6× 78 1.4× 19 523
Rajbharan Yadav United States 16 276 2.7× 118 1.5× 243 3.6× 78 1.3× 124 2.2× 29 567
Anil Kumar Sah Nepal 12 76 0.7× 39 0.5× 45 0.7× 43 0.7× 87 1.5× 38 339
Ryan L. Crass United States 12 136 1.3× 132 1.6× 315 4.7× 68 1.1× 22 0.4× 33 485
Prem Kapur India 12 22 0.2× 87 1.1× 37 0.6× 24 0.4× 42 0.7× 47 403
Hui Han China 12 95 0.9× 200 2.5× 39 0.6× 34 0.6× 68 1.2× 28 464
Yukihisa Miyazawa Japan 12 169 1.6× 107 1.3× 42 0.6× 56 0.9× 63 1.1× 37 488
Joakim Isendahl Sweden 6 130 1.3× 85 1.1× 135 2.0× 74 1.2× 94 1.6× 7 448
Takumi Umemura Japan 10 34 0.3× 105 1.3× 56 0.8× 30 0.5× 49 0.9× 41 273
Boyu Li China 10 24 0.2× 86 1.1× 26 0.4× 64 1.1× 97 1.7× 19 366

Countries citing papers authored by Yangmin Hu

Since Specialization
Citations

This map shows the geographic impact of Yangmin Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangmin Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangmin Hu more than expected).

Fields of papers citing papers by Yangmin Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangmin Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangmin Hu. The network helps show where Yangmin Hu may publish in the future.

Co-authorship network of co-authors of Yangmin Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Yangmin Hu. A scholar is included among the top collaborators of Yangmin Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangmin Hu. Yangmin Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Yangmin, Jing Cai, Meng Chen, et al.. (2025). Variations in ventricular distribution of polymyxin B following intraventricular administration in patients with central nervous system infections. Antimicrobial Agents and Chemotherapy. 70(3). e0094325–e0094325.
3.
Hu, Yangmin, et al.. (2024). Intraventricular or intrathecal polymyxin B for treatment of post-neurosurgical intracranial infection caused by carbapenem-resistant gram-negative bacteria: a 8-year retrospective study. European Journal of Clinical Microbiology & Infectious Diseases. 43(5). 875–884. 5 indexed citations
4.
He, Wei, et al.. (2024). Building a Hospital Pharmacist Workforce by a Diversified and Position-Oriented Learning System. Journal of Multidisciplinary Healthcare. Volume 17. 2989–2997.
5.
He, Wei, Yangmin Hu, Ying Yuan, et al.. (2023). Prevalence and influencing factors of probiotic usage among colorectal cancer patients in China: A national database study. PLoS ONE. 18(9). e0291864–e0291864. 3 indexed citations
6.
Lin, Haoran, et al.. (2023). The role of class IIa histone deacetylases in regulating endothelial function. Frontiers in Physiology. 14. 1091794–1091794. 13 indexed citations
7.
Yu, Lingyan, Wei He, Yangmin Hu, et al.. (2021). Antineoplastic prescription among patients with colorectal cancer in eight major cities of China, 2015–2019: an observational retrospective database analysis. BMJ Open. 11(10). e046166–e046166. 5 indexed citations
8.
Hu, Yangmin, Danyang Li, Yuping Hu, et al.. (2021). Epidemiology and outcomes of bloodstream infections in severe burn patients: a six-year retrospective study. Antimicrobial Resistance and Infection Control. 10(1). 98–98. 30 indexed citations
10.
Hu, Yangmin, et al.. (2018). Analysis of a pharmacist-led adverse drug event management model for pharmacovigilance in an academic medical center hospital in China. Therapeutics and Clinical Risk Management. Volume 14. 2139–2147. 12 indexed citations
12.
Lin, Xiaoyan, et al.. (2016). Emergence of Serratia marcescens isolates possessing carbapenem-hydrolysing β-lactamase KPC-2 from China. Journal of Hospital Infection. 94(1). 65–67. 13 indexed citations
13.
Hu, Yangmin, et al.. (2016). A retrospective study of risk factors for carbapenem-resistant Klebsiella pneumoniae acquisition among ICU patients. The Journal of Infection in Developing Countries. 10(3). 208–213. 43 indexed citations
14.
Tu, Hai‐Yan, et al.. (2016). Clinical analysis of hyperkalemic renal tubular acidosis caused by calcineurin inhibitors in solid organ transplant recipients. Journal of Clinical Pharmacy and Therapeutics. 42(1). 122–124. 8 indexed citations
15.
Zhang, Sai, Yangmin Hu, Yu-Wen Huang, et al.. (2015). Heat shock protein 27 promotes cell proliferation through activator protein-1 in lung cancer. Oncology Letters. 9(6). 2572–2576. 18 indexed citations
16.
Dai, Haibin, et al.. (2013). Pharmacist care and the management of coronary heart disease: a systematic review of randomized controlled trials. BMC Health Services Research. 13(1). 461–461. 37 indexed citations
17.
Li, Wenlu, et al.. (2013). Hydroxysafflor yellow A protects methylglyoxal-induced injury in the cultured human brain microvascular endothelial cells. Neuroscience Letters. 549. 146–150. 25 indexed citations
18.
Li, Wenlu, Hongjiao Xu, Yangmin Hu, et al.. (2013). Edaravone Protected Human Brain Microvascular Endothelial Cells from Methylglyoxal-Induced Injury by Inhibiting AGEs/RAGE/Oxidative Stress. PLoS ONE. 8(9). e76025–e76025. 34 indexed citations
19.
Hu, Yangmin, Wenlu Li, Huimin Xu, et al.. (2013). Combination antibiotic therapy versus monotherapy for Pseudomonas aeruginosa bacteraemia: A meta-analysis of retrospective and prospective studies. International Journal of Antimicrobial Agents. 42(6). 492–496. 55 indexed citations
20.
Hu, Yangmin, et al.. (2012). Efficacy of Rifaximin in Prevention of Travelers' Diarrhea: A Meta‐Analysis of Randomized, Double‐Blind, Placebo‐Controlled Trials. Journal of Travel Medicine. 19(6). 352–356. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026